CAMBRIDGE, Mass. (AP) _ Catabasis Pharmaceuticls Inc. (CATB) on Thursday reported a loss of $5.5 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 24 cents per share.
The biopharmaceutical company posted revenue of $250,000 in the period.
For the year, the company reported that its loss narrowed to $27.4 million, or $1.26 per share. Revenue was reported as $500,000.
In the final minutes of trading on Thursday, the company's shares hit $1.94. A year ago, they were trading at $1.75.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CATB at https://www.zacks.com/ap/CATB